Selma Bekri

Centre Hospitalier Universitaire de Rouen

ORCID: 0000-0003-2045-386X

Also affiliated with Université de Rouen Normandie

Immunology and MicrobiologyMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Phase 1 study combining elotuzumab with autologous stem cell transplant and lenalidomide for multiple myeloma”.

Phase 1 study combining elotuzumab with autologous stem cell transplant and lenalidomide for multiple myeloma

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-008110

N/A

0.309DataRank · unranked

5 citations

Keren Osman, Adolfo Aleman, Selma Bekri, Simone Kats, Amishi Dhadwal +8 more